EC Number |
Inhibitors |
Structure |
---|
2.5.1.21 | 1-(2-[2-[(4R,6S)-8-chloro-6-(2,3-dimethoxyphenyl)-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl]ethyl]-2H-1,2,3,4-tetrazol-5-yl)cyclopropanecarboxylic acid |
- |
|
2.5.1.21 | 1-(3-((4R,6S)-8-chloro-6-(2,3-dimethoxyphenyl)-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)propanoyl)-3-azetidine carboxylic acid |
- |
|
2.5.1.21 | 1-allyl-2-(3-anilinopropoxy)-9H-carbazole |
50% inhibition at above 0.001 mM nM |
|
2.5.1.21 | 1-allyl-2-[3-(benzylamino)propoxy]-9H-carbazole |
50% inhibition at 63 nM |
|
2.5.1.21 | 1-allyl-2-[3-(benzylamino)propoxy]-9H-carbazole hydrochloride |
50% inhibition at 150 nM |
|
2.5.1.21 | 1-allyl-2-[3-(cyclohexylamino)propoxy]-9H-carbazole |
50% inhibition at 310 nM |
|
2.5.1.21 | 1-allyl-2-[3-(cyclopropylamino)propoxy]-9H-carbazole |
50% inhibition at 230 nM |
|
2.5.1.21 | 1-allyl-2-[3-(isobutylamino)propoxy]-9H-carbazole |
50% inhibition at 400 nM |
|
2.5.1.21 | 1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole |
50% inhibition at 32 nM |
|
2.5.1.21 | 1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole |
50% inhibition at 66 nM |
|